Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

MagicMed Industries announced another collaboration as the company begins to develop PsyAI

MagicMed Industries announced another collaboration as the company begins to develop PsyAI

MagicMed Industries (CSE: MGIC) CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company is collaborating with two world-renowned scientists to create the one-of-a-kind PsyAI. This, according to Tucker will take psychedelic medicine out of the 1960s and into the 21st century.

Dr. Tucker talks more about why this is so important for the future development of pharmaceuticals and more about the two doctors that will be a part of this, Dr. Suran Goonatilake and Dr. Eric Nyberg.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK